Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Post by Kiluminati1984on Apr 16, 2021 9:14am
118 Views
Post# 33009868

Bipartisan Bills To Legalize Medical Weed For Military Vets

Bipartisan Bills To Legalize Medical Weed For Military VetsBipartisan Bills To Legalize Medical Marijuana For Military Veterans Introduced In Congress

A bipartisan coalition of congressional lawmakers on Thursday reintroduced legislation that would federally legalize medical marijuana for military veterans.

The bill is being sponsored by Reps. Barbara lee (D-CA) and Dave Joyce (R-OH), both co-chairs of the Congressional Cannabis Caucus, in the House, along with nine other original cosponsors. On the Senate side, Sen. Brian Schatz (D-HI) is leading the proposal, and he’s joined by five other lawmakers, including Sen. Bernie Sanders (I-VT).

The Veterans Medical Marijuana Safe Harbor Act would temporarily allow veterans to legally possess and use cannabis under federal law, as recommended by doctors in accordance with state law. Physicians with the U.S. Department of Veterans Affairs (VA) would also be allowed for the first time to issue such recommendations. Further, it would require VA to study the therapeutic potential of marijuana for pain and reducing opioid misuse.

Currently, VA allows its physicians to talk about cannabis use with veterans, but they’re prohibited from issuing recommendations that would allow them to obtain marijuana from state-legal markets.

Earlier versions of the companion bills were introduced in the last two Congresses but did not advance. With Democrats in control of both chambers and the White House this session, however, there’s renewed optimism that these types of cannabis proposals could move in 2021.

“It has been scientifically proven that medical marijuana has a considerable impact in treating conditions common with veterans when they return from service, like chronic pain and PTSD,” Lee said in a press release. “This legislation will empower veterans and their doctors to make informed decisions about the use of medical marijuana to treat chronic conditions in states with legal medical marijuana programs without federal interference.”

Joyce said that there’s “a growing body of evidence about the beneficial uses of medical cannabis as treatment for PTSD and chronic pain, two terrible conditions that plague many of our veterans.”

“If a state has made it legal, like Ohio has, the federal government should not be preventing a VA doctor from recommending medical cannabis if they believe that treatment is right for their patient,” he said. “I’m proud to join my colleagues in introducing this important bill and will continue to do everything in my power to ensure we are providing our veterans with the care they need to overcome the wounds of war.”

For the fiscal years 2022 and 2023, the bill would set aside $15 million for VA to administer the policy change.

The legalization and physician recommendation provisions of the legislation would expire after five years, unless renewed by Congress.

“In 36 states, doctors and their patients have the option to use medical marijuana to manage pain—unless those doctors work for the VA and their patients are veterans,” Schatz said. “This bill protects veteran patients in these states and gives their VA doctors the option to prescribe medical marijuana to veterans, and it also promises to shed light on how medical marijuana can help with the nation’s opioid epidemic.”

Bipartisan Bills To Legalize Medical Marijuana For Military Veterans Introduced In Congress | Marijuana Moment

<< Previous
Bullboard Posts
Next >>